keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RA-839 is a potent small molecule Keap1 conjugate and selective Nrf2 signalling activator, as well as an inhibitor of Keap1/Nrf2 interaction with anticancer activity.RA-839 inhibits the expression of inducible nitric oxide synthase and inhibits nitric oxide release.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 133.00 | |
10 mg | In stock | $ 195.00 | |
25 mg | In stock | $ 325.00 | |
50 mg | In stock | $ 483.00 |
Description | RA-839 is a potent small molecule Keap1 conjugate and selective Nrf2 signalling activator, as well as an inhibitor of Keap1/Nrf2 interaction with anticancer activity.RA-839 inhibits the expression of inducible nitric oxide synthase and inhibits nitric oxide release. |
Synonyms | RA 839, RA839 |
Molecular Weight | 452.57 |
Formula | C25H28N2O4S |
CAS No. | 1832713-02-6 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (176.77 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RA-839 1832713-02-6 Immunology/Inflammation Nrf2 RA 839 RA839 inhibitor inhibit